The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Skin Autofluorescence as a Noninvasive Marker of Vascular Damage in Patients With Type 2 Diabetes
Open accessAbstract
OBJECTIVE—Advanced glycation end products (AGEs) are thought to have a role in the pathogenesis of diabetes complications. We recently reported the association between skin autofluorescence, as a measure of tissue AGE accumulation, and diabetic neuropathy in a selected diabetic population. In this study, we investigated the relation between skin autofluorescence and clinical variables including micro- and macrovascular complications in a type 2 diabetes primary care population. RESEARCH DESIGN AND METHODS—Clinical data and skin autofluorescence were obtained in the type 2 diabetes group (n = 973) and in a control group (n = 231). Skin autofluorescence was assessed by illumination of the lower arm with a fluorescent tube (peak intensity ∼370 nm). RESULTS—Skin autofluorescence was significantly higher in type 2 diabetic patients compared with control subjects in each age category. Multiple regression analysis showed significant correlation of skin autofluorescence with age, sex, diabetes duration, BMI, smoking, HbA1c, plasma creatinine, HDL cholesterol, and albumin-to-creatinine ratio in the type 2 diabetes group (R2 = 25%) and with age and smoking in the control group (R2 = 46%). Skin autofluorescence was significantly higher in the type 2 diabetes group, with both micro- and macrovascular disease, compared with the group without complications and the group with only microvascular complications. CONCLUSIONS—This study confirms in a large group of type 2 diabetic patients that skin autofluorescence is higher compared with age-matched control subjects and is associated with the severity of diabetes-related complications. Skin autofluorescence reflecting vascular damage might be a rapid and helpful tool in the diabetes outpatient clinic for identifying diabetic patients who are at risk for developing complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Practical Statistics for Medical Research.
Walter, S. D., & Altman, D. G. (1992) · Biometrics · doi:10.2307/2532320 · Cited by 11,668
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
New classification of physical status
Dripps, R. B. (1963) · Anesthesiology · Cited by 1,676
Effect of Collagen Turnover on the Accumulation of Advanced Glycation End Products
Verzijl, N., DeGroot, J., Thorpe, S. R., Bank, R. A., Shaw, J. N., Lyons, T. J., Bijlsma, J. W. J., Lafeber, F. P. J. G., Baynes, J. W., & TeKoppele, J. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006700200 · Cited by 963
Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer, D. G., Dunn, J. A., Thorpe, S. R., Bailie, K. E., Lyons, T. J., McCance, D. R., & Baynes, J. W. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116481 · Cited by 769
Simple non-invasive assessment of advanced glycation endproduct accumulation
Meerwaldt, R., Graaff, R., Oomen, P. H. N., Links, T. P., Jager, J. J., Alderson, N. L., Thorpe, S. R., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2004) · Diabetologia · doi:10.1007/s00125-004-1451-2 · Cited by 766
Self-citationGlycation and Diabetic Complications
Brownlee, M. (1994) · Diabetes · doi:10.2337/diab.43.6.836 · Cited by 632
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
Monnier, V. M., Vishwanath, V., Frank, K. E., Elmets, C. A., Dauchot, P., & Kohn, R. R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602133140702 · Cited by 585
Tobacco smoke is a source of toxic reactive glycation products
Cerami, C., Founds, H., Nicholl, I., Mitsuhashi, T., Giordano, D., Vanpatten, S., Lee, A., Al-Abed, Y., Vlassara, H., Bucala, R., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13915 · Cited by 549
Glycoxidation and lipoxidation in atherogenesis
Baynes, J. W., & Thorpe, S. R. (2000) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00228-8 · Cited by 514
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Genuth, S., Sun, W., Cleary, P., Sell, D. R., Dahms, W., Malone, J., Sivitz, W., Monnier, V. M., & for the DCCT Skin Collagen Ancillary Study Group (2005) · Diabetes · doi:10.2337/diabetes.54.11.3103 · Cited by 427
Meerwaldt, R., Hartog, J. W. L., Graaff, R., Huisman, R. J., Links, T. P., den Hollander, N. C., Thorpe, S. R., Baynes, J. W., Navis, G., Gans, R. O. B., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005020144 · Cited by 396
Self-citationTHORPE SR ROLE OF OXIDATIVE STRESS IN DIABETIC COMPLICATIONS: A NEW PERSPECTIVE ON AN OLD PARADIGM
Baynes, J. (1999) · Cited by 326
High and low hemoglobin glycation phenotypes in type 1 diabetes
Hempe, J. M., Gomez, R., McCarter, R. J., & Chalew, S. A. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(01)00227-6 · Cited by 322
Sell, D. R., Lapolla, A., Odetti, P., Fogarty, J., & Monnier, V. M. (1992) · Diabetes · doi:10.2337/diab.41.10.1286 · Cited by 310
Beisswenger, P. J., Makita, Z., Curphey, T. J., Moore, L. L., Jean, S., Brinck-Johnsen, T., Bucala, R., & Vlassara, H. (1995) · Diabetes · doi:10.2337/diab.44.7.824 · Cited by 253
Meerwaldt, R., Links, T. P., Graaff, R., Hoogenberg, K., Lefrandt, J. D., Baynes, J. W., Gans, R. O. B., & Smit, A. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1828-x · Cited by 181
Self-citationEffects of postmenopausal hypoestrogenism on skin collagen
Affinito, P., Palomba, S., Sorrentino, C., Di Carlo, C., Bifulco, G., Arienzo, M. P., & Nappi, C. (1999) · Maturitas · doi:10.1016/s0378-5122(99)00077-8 · Cited by 170
Autofluorescence of Human Skin is Age-Related After Correction for Skin Pigmentation and Redness
Na, R., Stender, I., Henriksen, M., & Wulf, H. C. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.01285.x · Cited by 155
Ubink-Veltmaat, L. J., Bilo, H. J. G., Groenier, K. H., Houweling, S. T., Rischen, R., & Jong, B. M. (2003) · European Journal of Epidemiology · doi:10.1023/a:1025369623365 · Cited by 154
Self-citationMontori, V. M., Dinneen, S. F., Gorman, C. A., Zimmerman, B. R., Rizza, R. A., Bjornsen, S. S., Green, E. M., Bryant, S. C., Smith, S. A., & for The Translation Project Investigator Group (2002) · Diabetes Care · doi:10.2337/diacare.25.11.1952 · Cited by 142
Valk, G. D., de Sonnaville, J. J. J., van Houtum, W. H., Heine, R. J., van Eijk, J. T. M., Bouter, L. M., & Bertelsmann, F. W. (1997) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199701)20:1<116::aid-mus19>3.0.co;2-2 · Cited by 129
Stitt, A. W., He, C., Friedman, S. G., Scher, L. A., Rossi, P., Ong, L., Founds, H., Li, Y. M., Bucala, R., & Vlassara, H. (1997) · Molecular Medicine · doi:10.1007/bf03401819 · Cited by 126
Long-term assessment of glucose control by haemoglobin-AGE measurement
Wolffenbuttel, B. H. R., Giordano, D., Founds, H., & Bucala, R. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91141-1 · Cited by 104
Accumulation of Advanced Glycation End Products, Measured as Skin Autofluorescence, in Renal Disease
Hartog, J. W. L., de Vries, A. P. J., Lutgers, H. L., Meerwaldt, R., Huisman, R. M., van Son, W. J., de Jong, P. E., & Smit, A. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.037 · Cited by 89
Self-citationSerum levels of low molecular weight advanced glycation end products in diabetic subjects
Sharp, P. S., Rainbow, S. J., & Mukherjee, S. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00973.x · Cited by 79
Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes
Thomas, M. C., Tsalamandris, C., MacIsaac, R. J., Medley, T. L., Kingwell, B. A., Cooper, M. E., Jerums, G., & Alberti, D. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00868.x · Cited by 72
Hricik, D. E., Wu, Y. C., Schulak, J. A., & Friedlander, M. A. (1996) · Clinical Transplantation · doi:10.1111/j.1399-0012.1996.tb00747.x · Cited by 59
Factors in human serum interfere with the measurement of advanced glycation endproducts.
Dorrian, C. A., Cathcart, S., Clausen, J., Shapiro, D., & Dominiczak, M. H. (1998) · PubMed · Cited by 46
Cited by
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Advanced glycation end products: Key players in skin aging?
Gkogkolou, P., & Böhm, M. (2012) · Dermato-Endocrinology · doi:10.4161/derm.22028 · Cited by 584
Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms
Stirban, A., Gawlowski, T., & Roden, M. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.006 · Cited by 361
Da Moura Semedo, C., Webb, M., Waller, H., Khunti, K., & Davies, M. (2017) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2016-134579 · Cited by 81
de Vos, L. C., Lefrandt, J. D., Dullaart, R. P. F., Zeebregts, C. J., & Smit, A. J. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.10.012 · Cited by 77
Self-citation
Metadata
- Authors
- Lutgers, H. L., Graaff, R., Links, T. P., Ubink-Veltmaat, L. J., Bilo, H. J., Gans, R. O., & Smit, A. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2006-12-01
- Volume
- 29
- Issue
- 12
- Pages
- 2654-2659
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2122567972
- Cited by
- 264
- References
- 31
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.